Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$13.9 - $23.88 $72,043 - $123,770
5,183 New
5,183 $72,000
Q2 2023

Jul 18, 2023

BUY
$22.4 - $34.92 $1,187 - $1,850
53 Added 1.39%
3,873 $89,000
Q1 2023

Apr 13, 2023

SELL
$24.84 - $38.75 $26,703 - $41,656
-1,075 Reduced 21.96%
3,820 $113,000
Q4 2022

Jan 23, 2023

SELL
$19.57 - $30.92 $1,056 - $1,669
-54 Reduced 1.09%
4,895 $0
Q3 2022

Oct 26, 2022

SELL
$20.91 - $34.27 $23,272 - $38,142
-1,113 Reduced 18.36%
4,949 $107,000
Q2 2022

Jul 25, 2022

SELL
$14.13 - $42.55 $213,843 - $643,951
-15,134 Reduced 71.4%
6,062 $119,000
Q1 2022

May 02, 2022

BUY
$35.3 - $64.68 $30,534 - $55,948
865 Added 4.25%
21,196 $897,000
Q4 2021

Jan 28, 2022

BUY
$49.91 - $65.56 $1.01 Million - $1.33 Million
20,331 New
20,331 $1.29 Million

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.3B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.